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Abstract
Background
Evidence suggests that lower serum undercarboxylated osteocalcin (ucOC) may be negatively
associated with cardiometabolic health. We investigated whether individuals with the largest
suppression of ucOC following an increase in dietary vitamin K1, exhibit a relative worsening
of cardiometabolic risk factors.
Materials and Methods
Men (n = 20) and women (n = 10) aged 62 ± 10 years participated in a randomised,
controlled, cross-over study. The primary analysis involved using data obtained from
participants following a high vitamin K1 diet (HK; 4-week intervention of increased leafy
green vegetable intake). High and low responders were defined based on the median percent
reduction (30%) in ucOC following the HK diet. Blood pressure (resting and 24-hour), arterial
stiffness, plasma glucose and lipid concentrations, and serum OC forms were assessed.
Results
Following the HK diet, ucOC and ucOC/tOC were suppressed more (p < 0.01) in high
responders (41% and 29%) versus low responders (12% and 10%). The reduction in ucOC
and ucOC/tOC was not associated with changes in blood pressure, arterial stiffness, plasma
glucose or lipid concentrations in the high responders (p > 0.05).
Discussion/Conclusion
Suppression of ucOC via consumption of leafy green vegetables has no negative effects on
cardiometabolic

health,

perhaps,

in

part,

because

of

cross-talk

mechanisms.
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1. Introduction
Cardiovascular disease (CVD) is the leading cause of death worldwide [1]. A diet rich in fruit
and vegetables is an important, non-therapeutic approach to reduce CVD development and
progression [2, 3]. Evidence suggests that diets rich in green leafy vegetables increase nitric
oxide bioavailability and can improve vascular health [4, 5]. However, we have previously
shown that a 4-week dietary intervention involving an increased intake of leafy green
vegetables, did not reduce blood pressure (BP) or arterial stiffness [6]. One potential
explanation for the absence of a beneficial effect on BP and arterial stiffness may be related to
other bioactive components found in leafy green vegetables that concomitantly influence
vascular health. For example, vitamin K1 is abundant in leafy green vegetables and regulates
several coagulation factors including vitamin K-dependent proteins (VKDP) [7].
One such protein is osteocalcin (OC), a VKDP derived from osteoblasts that exists in two
forms: carboxylated OC (cOC) and undercarboxylated OC (ucOC) [8-10]. cOC has a high
affinity to hydroxyapatite within the bone matrix and is therefore thought to reflect bone
mineralisation [11, 12], whereas ucOC is proposed as the bioactive form of OC in several
target tissues [13]. Growing evidence suggests an association between OC, in particular total
OC (tOC) and ucOC with hypertension, vascular calcification, atherosclerosis and CVD
mortality [14-17]. However, the literature is conflicting and it is unclear whether tOC or its
isoforms are associated with positive or negative effects on cardiometabolic health [18, 19].
We have previously shown that a diet rich in leafy green vegetables, and thus vitamin K1,
reduces circulating ucOC levels [20].
The current study was a sub-analysis examining the cardiometabolic implications of ucOC
suppression following an increased intake of predominantly leafy green vegetables. It was of
interest to investigate whether a reduction in ucOC levels was correlated with changes in
cardiometabolic risk factors, and whether this could explain, at least in part, the lack of a
beneficial effect on blood pressure following an increase in dietary nitrate. Participants from
the high vitamin K1 intervention were divided into high/low responders based on the
suppression of ucOC following the intervention. The aim was to determine if a large reduction
in ucOC (high responders) would be associated with alterations in cardiometabolic risk
factors including blood pressure, arterial stiffness, blood glucose and lipid concentrations.
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2. Methods
The data for this paper was collected for the Vegetable Intake and Blood Pressure (VIABP)
study (ACTRN12615000194561). The study was approved by The University of Western
Australia Human Research Ethics Committee and was completed in accordance with the
Declaration of Helsinki. Written informed consent was obtained from all participants. The
study was a randomised, controlled crossover trial and methodology has been described in full
elsewhere [6]. In brief, middle and older aged (40 to 74 years of age) community dwelling
men and women with pre-hypertension or untreated grade one hypertension were recruited to
participate. Each participant received three 4-week dietary interventions, each interspersed
with a 4-week washout period. The VIABP study was originally designed with the following
dietary interventions: (1) increased intake of nitrate-rich leafy green vegetables (high nitrate);
(2) increased intake of nitrate-poor vegetables (low nitrate); and (3) no increase in vegetables
(control). As vitamin K1 is also found predominately in leafy green vegetables, these three
dietary interventions have been equated to: (1) high vitamin K1 intake (HK); (2) low vitamin
K1 intake (LK); and (3) control diet (CON) [20]. Considering the primary aim of this study is
to examine the association between the suppression of ucOC and cardiometabolic risk factors
(and given the LK diet did not suppress ucOC), we predominantly considered data from the
HK intervention.
Resting BP and pulse wave velocity (PWV) (SphygmoCor XCEL 2012, AtCor Medical Pty.
Ltd.) were measured pre and post the 4-week dietary intervention, as previously described [6].
Ambulatory BP was recorded over a 24-hour period, every 20 minutes during the day and
every 30 minutes during the night, mean BP was determined for the 24-hour period [6].
Plasma concentrations of glucose, triglycerides, total cholesterol, HDL cholesterol and
calculated LDL cholesterol were analysed by PathWest laboratories (Fiona Stanley Hospital,
Perth, Australia). Serum tOC was measured by sandwich electrochemiluminescence
immunoassay using the Roche Cobas N-Mid OC assay (Roche Diagnostics, Mannheim). The
inter-assay coefficients of variation were 2.3% and 4.8% at levels of 18 and 90 ng/mL,
respectively. Serum ucOC was determined using the hydroxyapatite binding method
(Calbiochem) [21]. The inter-assay imprecision for percentage binding of cOC was 8% and
12% at OC of 100 and 15 ng/mL, respectively. Plasma creatinine was measured at baseline
and glomerular filtration rate (GFR) was estimated using plasma creatinine levels based on
the known equation [22]. Vitamin K intake was estimated as previously described [20].
4

Statistical analysis
All statistical analysis was performed using Statistical Package for the Social Sciences (SPSS
Inc. Chicago, IL, USA, version 22). Independant samples t-tests were conducted to examine
OC concentrations between males and females and if characteristics known to influence ucOC
(BMI, age, vitamin K intake and GFR) were different between the high responders and low
responders at baseline. Spearman rho correlations were used to assess the relationship
between pre-intervention OC concentrations and pre-intervention outcome measures.
Spearman partial correlations were used for the additional adjustments of age and body mass
index (BMI) as they are strong influencers of ucOC levels [23, 24].
When considering post intervention data from the HK diet intervention, participants were
divided into high responders (suppression of ucOC ≥ median [≥ 30%]) and low responders
(suppression of ucOC < median [< 30%]), based on the percent change in ucOC. The between
groups (high versus low responders) effect of the HK diet on changes in OC, vascular and
metabolic outcomes were assessed using one-way ANOVA. Within groups effects for preand post-intervention were assessed using paired samples t-tests, as previously reported [20].
All data reported as mean ± SEM and statistical analysis was conducted at the 95%
confidence level of significance (p < 0.05).
3. Results
Baseline characteristics are presented in Table 1. Serum tOC, cOC and ucOC levels at preintervention data points were not different between women (n = 10) or men (n = 20) (p > 0.05
for all, Table 1). With pre-intervention data points combined together, a higher ucOC/tOC
ratio was associated with lower PWV when adjusted for BMI and age (r = -0.493, p < 0.05).
A higher concentration of cOC was associated with a higher PWV when adjusted for BMI and
age (r = .638, p < 0.01). All other pre-intervention correlations were not significant (p > 0.05
for all, Supplementary Table 1).
We have previously shown that the HK intervention, but not the LK or CON intervention
suppressed tOC, ucOC and the ucOC/tOC ratio [20]. In the high responders tOC, ucOC and
ucOC/tOC were reduced post-intervention compared to pre-intervention, following the 4week HK diet (p < 0.001 for all, Table 2). Whilst in the low responders, ucOC (p < 0.001)
and ucOC/tOC (p < 0.01), as well as resting systolic BP (2%, p < 0.05) were reduced post
intervention. As expected, the change in ucOC and ucOC/tOC ratio was significantly greater
in the high responders versus low responders (p < 0.05 for both, Table 2). The change in tOC,
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cOC, markers of vascular (ambulatory systolic BP, ambulatory diastolic BP, resting systolic
BP, resting diastolic BP or PWV) and metabolic (glucose, total cholesterol, LDL, HDL or
triglycerides) health were not significantly different between the low and high responders
(Table 2). There was no difference in BMI, vitamin K intake, age or estimated GFR (eGFR)
between the high or low responders at baseline (p > 0.05 for all, Supplementary Table 2).
Using unadjusted Spearman rho correlation and Spearman partial correlation there was no
association between the change in ucOC or the ucOC/tOC ratio with the change in any
cardiometabolic risk factor in the high responders (p > 0.05 for all, Table 3). Using
unadjusted spearman rho correlation, a positive association was present between the change in
ucOC and the change in LDL when all participants were combined (i.e. high and low
responders combined) (p < 0.05, Table 3). When adjusted for age and BMI using Spearman
partial correlations, a positive correlation was present between the change in ucOC/tOC ratio
and change in ambulatory diastolic BP when all participants were combined (r = .435, p <
0.05). In low responders only, there was a strong positive correlation between the change in
ucOC/tOC ratio and change in glucose levels (r = .793, p < 0.05). All other correlations were
not significant (p > 0.05 for all, Table 3).
4. Discussion
The major finding of this study is that the suppression of ucOC was not associated with
increased cardiometabolic risk factors, even in individuals who responded the most to the
intervention (high responders). As such, it appears that the suppression of ucOC following a
leafy green-rich diet does not impact, either negatively or positively, on cardiometabolic risk
factors.
Currently, there are conflicting reports regarding the relationship between OC and blood
pressure. Some have reported that lower tOC levels are associated with a higher prevalence of
hypertension in adult men and women [25, 26]. Others however, have described no
association between tOC and systolic or diastolic BP in adult men and women [27, 28]. As
cOC and ucOC may have diverse biological functions, the examination of tOC alone, as often
reported in these studies, limits our understanding of the exact function of each form of OC
[23, 29]. In the current study, we have examined each form of OC and report that a reduction
in ucOC and ucOC/tOC ratio via dietary modification is not correlated with changes in BP.
This is interesting and suggests several possibilities. Firstly, ucOC may simply not have a
6

regulatory role in the maintenance of blood vessel function and BP. Secondly, the HK (leafy
green rich) diet may regulate other bioactive factors that influence vascular health. For
example, we have previously shown that the 4-week leafy green-rich diet increased plasma
nitrate levels [6]. An increase in plasma nitrate enhances the bioavailability of nitric oxide, an
anti-atherogenic molecule that regulates blood vessel function and BP [4, 30]. ucOC has also
been implicated as a regulatory factor responsible for the maintenance of blood vessel
function and BP [19]. Therefore, it is possible that the reduction in ucOC was offset by an
increase in NO bioavailability. Consequently, cross-talk mechanisms may exist, which may
explain the lack of changes in BP. This hypothesis should be explored in further mechanistic
studies.
ucOC has been established as a regulator of energy homeostasis, at least in animal models
[31, 32]. A large number of cross-sectional studies in humans show that ucOC is associated
with metabolic responses and diseases. For example, a reduction in circulating ucOC is
associated with an increased risk or presence of metabolic disorders, such as metabolic
syndrome and type 2 diabetes [17]. Lower circulating tOC and ucOC has been associated with
increased concentrations of blood glucose and triglycerides and decreased levels of HDL [33,
34]. However, few interventional studies have modified ucOC and examined the effect on
metabolic outcomes. One study administered a single dose of prednisolone, a glucocorticoid,
which suppressed circulating tOC and ucOC and also caused a reduction in insulin sensitivity
and fasting blood glucose [35, 36]. In the current study, despite a 41% reduction in ucOC and
29% reduction in ucOC/tOC after the HK diet, there were no changes in fasting glucose or
lipid levels in the high responders. Potential mechanisms for the lack of change are not clear,
but it may be related to other bioactive components present in green leafy vegtables that can
caused a compensatory effect and prevented any change in metabolic variables.
The development of vascular calcification is a process comparable to the development of bone
within the skeleton. As OC is involved in bone mineralisation within the skeleton, it has also
been implicated in the development of mineralisation within the vasculature [37, 23]. cOC, is
the form of OC most involved with bone development in the skeleton, as such, it is possible
that cOC is the form of OC involved in the development of calcification within the
vasculature. However, research in this area is lacking. We have shown that baseline cOC is
associated with baseline PWV, a measure of arterial stiffness which suggests the presence of
vascular calcificaton [38]. However, we saw no correlation of cOC with PWV following the
7

HK diet in the high or low responders. Whilst, it is possible that OC is involved in vascular
calcification, future large scale studies are needed to assess the effect of each form of OC, in
particular cOC, on arterial stiffness and the development of vascular calcification.
A limitation of the current study is that the 4-week intervention period may not have been
long enough or the dose of vitamin K1 large enough to observe a change in measures of
cardiometabolic risk. Previous studies administering vitamin K1 supplementation (500 1000µg p/day) for 3 years found improvements in vascular compliance and reductions in
coronary artery calcification [39, 40]. In the current study, it was estimated that participants
increased their vitamin K1 intake by ~150 µg p/day over the 4-weeks [20]. As such, a
prolonged intervention may be needed to demonstrate changes in cardiometabolic risk factors.
Another potential limitation was the inclusion of people who are relatively healthy. It is
possible that those with diabetes or cardiovascular disease will respond differently to the
intervention and that the correlation between ucOC and cardiovascular risk factors may be
apparent in these populations. Finally, the generalisation of the results are somewhat limited
due to the relatively small sample size. As such, further large scale studies, in particular
RCTs, are needed to confirm our findings.
In conclusion, this study demonstrated that the suppression of ucOC following increased daily
intake of leafy green vitamin K1-rich vegetables over 4-weeks was not associated with
unfavourable changes in cardiometabolic risk factors. This may be due to the presence of
compensatory mechanisms, or the fact that ucOC has a limited regulatory role over
cardiometabolic risk factors in apparently healthy individuals. Such hypothesis should be
explored by future mechanistic studies.
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